These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6138864)

  • 21. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of a new beta blockader on behavior of some parameters of aerobic metabolism during the effort test].
    Carù B; Cadel A
    Boll Soc Ital Cardiol; 1971; 16(5):221-6. PubMed ID: 4400447
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of beta blockaders in patients with ischemic heart disease during in-hospital rehabilitation after aortocoronary bypass surgery].
    Osanova MV; Malikov VE; Rogov SV; Petrunina LV
    Klin Med (Mosk); 1994; 72(2):25-8. PubMed ID: 8015235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intrinsic sympathicomimetic activity of beta blockers].
    Beckers J
    Rev Med Liege; 1988 Oct; 43(19):613-22. PubMed ID: 2903532
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of Anaprillin on the transport of electrolytes and hemodynamics].
    Shulga IuD; Zharko KP
    Vrach Delo; 1973 Sep; 9():46-8. PubMed ID: 4148974
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beta-blockaders. Their pharmacology and clinical use].
    Tomov L; Elenkova A; Nikolov GT
    Vutr Boles; 1978; 17(5):1-12. PubMed ID: 31033
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in hemodynamics during exercise in patients with ischemic heart disease].
    Koeda T; Ichikawa T; Sato M; Miura S; Yoshinaga S; Nasu M; Fujimori M; Aoki H; Ohsawa K; Oda M
    Kokyu To Junkan; 1985 Sep; 33(9):1131-5. PubMed ID: 4070825
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
    Petrov IN; Rumiantsev AS; Smirnov MV
    Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting maximum heart rate among patients with coronary heart disease receiving beta-adrenergic blockade therapy.
    Brawner CA; Ehrman JK; Schairer JR; Cao JJ; Keteyian SJ
    Am Heart J; 2004 Nov; 148(5):910-4. PubMed ID: 15523326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1983 Jan; (1):15-8. PubMed ID: 6868490
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience in treatment of patients with ischemic heart disease by means of beta adrenergic blocking agents].
    Lebedev SV
    Klin Med (Mosk); 1977 May; 55(5):54-7. PubMed ID: 17769
    [No Abstract]   [Full Text] [Related]  

  • 32. The cardiovascular effects of celiprolol in healthy volunteers and patients with coronary heart disease.
    Hitzenberger G
    Br J Clin Pract Suppl; 1985 Jun; 40():46-51. PubMed ID: 2864064
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experiences with treating coronary artery disease with adrenergic beta receptor blockaders].
    Szulc EJ
    Wiad Lek; 1972 Dec; 25(23):2093-7. PubMed ID: 4405150
    [No Abstract]   [Full Text] [Related]  

  • 37. [Beta-adrenergic receptor blockers in the treatment of chronic heart failure].
    Mularek-Kubzdela T; Grajek S; Cieśliński A
    Pol Merkur Lekarski; 1996 Aug; 1(2):120-3. PubMed ID: 9156910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of beta adrenergic receptor blockaders studied with propranolol on the ventricular repolarizzation in patients with hypertensive heart disease and chronic coronary insufficiency].
    Zani D; Melara D
    Cardiol Prat; 1969 Jun; 20(3):211-27. PubMed ID: 5407605
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of the initial forms of ischemic heart disease].
    Ianovskiĭ GV
    Vrach Delo; 1980 Apr; (4):32-4. PubMed ID: 6104382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.